Related Experiment Video

Updated: Jun 4, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

MicroRNA dysregulation in colorectal cancer: a clinical perspective

Y Dong1, W K K Wu, C W Wu

  • 1Institute of Digestive Disease and Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong Kong, China.

British Journal of Cancer
|March 3, 2011
PubMed

Insights

MicroRNAs (miRNAs) show promise as early diagnostic and prognostic biomarkers for colorectal cancer (CRC). Further research is needed to fully characterize these noninvasive markers for clinical application.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • MicroRNAs (miRNAs) play a crucial role in colorectal cancer (CRC) development, progression, and treatment response.
  • Early detection and accurate prognostication are critical for improving CRC patient outcomes.

Purpose of the Study:

  • To review the latest advancements in identifying noninvasive plasma and fecal miRNAs for early CRC diagnosis.
  • To discuss the potential of miRNAs as prognostic and predictive markers in CRC.
  • To explore the influence of miRNA-related single-nucleotide polymorphisms on CRC susceptibility and treatment.

Main Methods:

  • Comprehensive literature review of recent research on miRNAs in colorectal cancer.
  • Analysis of studies focusing on noninvasive miRNA detection in plasma and feces.
  • Evaluation of miRNA association with CRC clinical phenotypes and therapeutic outcomes.
  • Summary of findings on miRNA-related single-nucleotide polymorphisms and sporadic CRC.

Main Results:

  • Noninvasive plasma and fecal miRNAs demonstrate potential for early CRC diagnosis, with ongoing evaluation of their measurability and predictability.
  • miRNAs are emerging as valuable prognostic and predictive markers, correlating with CRC recurrence, metastasis, and treatment success.
  • miRNA-related single-nucleotide polymorphisms may impact sporadic CRC risk and response to therapy.

Conclusions:

  • The application of miRNAs as biomarkers for colorectal cancer is still in its early stages.
  • Further characterization and validation are essential to realize the full clinical potential of miRNAs in CRC management.

More Related Videos

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...